Evidence map›Paper›PMID 23850459›Full record

ArticleVirology2013

Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease.

Linda L Dunn, Paul L Boyer, Patrick K Clark, Stephen H Hughes

Abstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.Microbiology and molecular biology reviews : MMBR · 2016
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Linda L DunnHIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, PO Box B, Frederick, MD 21702, USA. dunnli@mail.nih.gov
Paul L Boyer
Patrick K Clark
Stephen H Hughes
National Institutes of Health · USScience Applications International Corporation (United States) · US

Funding

Structure and Function of HIV-1 Reverse TranscriptaseZIABC010481 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUGHES, STEPHEN H · 2009 to 2022
$15.7M
Intramural NIH HHS ZIA BC010481PHS HHS HHSN26120080001E
6 · The paper itself

Abstract

Previous work on mutations in the thumb of HIV-1 reverse transcriptase (RT) showed that the majority of the mutant RTs were degraded (by the viral protease) to various extents in virions. This degradation was, in most cases, temperature sensitive, and presumably was due to a partial unfolding of the protein at 37°C. We used recombinant proteins to investigate the effects of the mutations on the thermal stability and proteolytic degradation of RT. Both subunits contribute to the stability of RT. In general, the differences in stability between the mutants and WT were greater if the mutation was in p51 rather than p66. Expressing the Pol polyprotein containing the RT mutants in Escherichia coli produced results similar to what was seen in virions; the mutant RTs were misfolded and/or degraded at 37°C, but were better folded and processed at 30°C.

Indexed as

Protein FoldingEnzyme StabilityEscherichia coliHIV-1HIV ProteaseHIV Reverse TranscriptaseMutant ProteinsProtein StabilityProteolysisRecombinant ProteinsTemperatureHIV ProteaseHIV Reverse TranscriptaseMutant ProteinsRecombinant Proteinsreverse transcriptase, Human immunodeficiency virus 1Differential scanning fluorescenceHIV-1ProteaseReverse transcriptaseStability

Identifiers

PMID23850459
PMCPMC3804327
OpenAlexW2054190500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.